CytomX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.About CTMX
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W.
CEOSean A. McCarthy
CEOSean A. McCarthy
Employees121
Employees121
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2010
Founded2010
Employees121
Employees121
CTMX Key Statistics
Market cap806.51M
Market cap806.51M
Price-Earnings ratio12.12
Price-Earnings ratio12.12
Dividend yield—
Dividend yield—
Average volume2.40M
Average volume2.40M
High today$5.10
High today$5.10
Low today$4.67
Low today$4.67
Open price$5.00
Open price$5.00
Volume2.46M
Volume2.46M
52 Week high$6.35
52 Week high$6.35
52 Week low$0.40
52 Week low$0.40
Stock Snapshot
CytomX(CTMX) stock is priced at $4.85, giving the company a market capitalization of 806.51M. It carries a P/E multiple of 12.12.
During the trading session on 2026-03-05, CytomX(CTMX) shares reached a daily high of $5.10 and a low of $4.67. At a current price of $4.85, the stock is +3.9% higher than the low and still -4.9% under the high.
Trading activity shows a volume of 2.46M, compared to an average daily volume of 2.4M.
Over the past 52 weeks, CytomX(CTMX) stock has traded between a high of $6.35 and a low of $0.40.
Over the past 52 weeks, CytomX(CTMX) stock has traded between a high of $6.35 and a low of $0.40.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own CTMX. This list is generated using Robinhood data, and it’s not a recommendation.